FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof:
as well as a compound of formula (I-a) or a pharmaceutically acceptable salt thereof:
a compound represented by the following formula (Id), or a pharmaceutically acceptable salt thereof:
specific compounds selected from the group, a pharmaceutical composition, a method of preparing a pharmaceutical composition and use of compounds of formula (I) and (I-a) for preparing a medicinal agent for treating a condition or disorder mediated by TRPV4 receptor antagonist activity.
EFFECT: obtaining novel compounds which can be used as TRPV4 receptor modulators for treating a wide range of diseases, syndromes and disorders, in particular for the treatment of inflammatory, pain and urological diseases or disorders.
18 cl, 277 tbl, 1105 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL REMEDIES FOR TREATMENT AND PREVENTION OF HIV INFECTION | 2021 |
|
RU2780103C1 |
ANTIVIRAL REMEDIES FOR TREATMENT AND PREVENTION OF HIV INFECTION | 2020 |
|
RU2780101C2 |
BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF | 2007 |
|
RU2434872C2 |
PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | 2009 |
|
RU2473549C2 |
NOVEL DERIVATIVES OF 1,2,3,4-TETRAHYDROPYRIMIDO{1,2-a}PYRIMIDIN-6-ONE, OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2010 |
|
RU2561130C2 |
SUBSTITUTED COMPOUNDS OF THIOPHEN AND FURAN-CONDENSED AZOLOPYRIMIDIN-5-(6H)-OH | 2013 |
|
RU2659779C2 |
NEW TETRAHYDROPYRIMIDINE CONNECTION OR ITS SALT | 2015 |
|
RU2636310C1 |
CONDENSED PYRIDAZINE DERIVATIVES AND DRUGS HAVING THE COMPOUNDS AS ACTIVE INGREDIENTS | 2003 |
|
RU2292337C2 |
POLY(ADP-RIBOSO)POLYMERASE INHIBITORS | 2007 |
|
RU2455286C2 |
Authors
Dates
2025-05-28—Published
2021-04-30—Filed